Currently, the use of tumor infiltrated lymphocyte quantification to stratify patients and predict survival is rising, with a score system called ImmunoscoreTM, based on the CD3+ CD8+ T cells and memory T (CD45RO+) density in CRC (22–24). Here, CD8A is linked to neoplasm.